Rtw Investments, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $6.27 Billion distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Madrigal Pharmaceuticals, Inc. with a value of $423M, Axsome Therapeutics, Inc. with a value of $376M, Avidity Biosciences, Inc. with a value of $374M, Argenx Se with a value of $355M, and Natera, Inc. with a value of $330M.

Examining the 13F form we can see an increase of $285M in the current position value, from $5.99B to 6.27B.

Rtw Investments, LP is based out at New York, NY

Below you can find more details about Rtw Investments, LP portfolio as well as his latest detailed transactions.

Portfolio value $6.27 Billion
Healthcare: $6.27 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $6.27 Billion
  • Prior Value $5.99 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 11 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.